Drug Profile
Research programme: small molecule inhibitors - BIOSCORA
Alternative Names: CDK2/cyclin A kinase inhibitors; Multidrug resistant protein MDR1Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator BIOSCORA
- Class Small molecules
- Mechanism of Action Cyclin-dependent kinase 2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in Germany
- 08 Dec 2005 Preclinical trials in Cancer in Germany (unspecified route)